Jonathan Lerner, MD
Clinical Cardiac Electrophysiology · Chula Vista, CANPI 1962899823
Payments from drug & device makers
Across 508 payments — averaging $59.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Medtronic$7K
- Boston Scientific$6K
- Biosense Webster, Inc.$3K
- Medical Device Business Services, Inc.$1K
- Cardiva Medical, Inc.$1K
- plus $5K from 33 others
What the payments were for
- Consulting fees$1,1254%
- Grants$1,4845%
- Travel & lodging$6,60822%
- Food & beverage$20,63968%
- Education$4291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 107 | $7,399 |
| Medtronic | 59 | $6,627 |
| Boston Scientific | 88 | $5,954 |
| Biosense Webster, Inc. | 53 | $2,979 |
| Medical Device Business Services, Inc. | 5 | $1,196 |
| Cardiva Medical, Inc. | 65 | $1,040 |
| Biotronik Inc. | 7 | $735 |
| Johnson & Johnson(2 entities) | 37 | $682 |
| Abiomed | 10 | $505 |
| Cook Medical LLC | 8 | $466 |
| Cook Incorporated | 2 | $444 |
| Edwards Lifesciences | 2 | $367 |
| Heartflow, Inc. | 2 | $276 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $266 |
| Amgen | 6 | $208 |
| AOP Health US, LLC | 1 | $169 |
| Novo Nordisk | 6 | $106 |
| Novartis | 5 | $96 |
| Terumo Medical Corporation | 3 | $70 |
| Pfizer | 4 | $67 |
| Altathera Pharmaceuticals LLC | 2 | $55 |
| Merck | 2 | $50 |
| Shockwave Medical, Inc | 1 | $47 |
| AstraZeneca | 2 | $45 |
| Astellas Pharma US Inc | 2 | $42 |
| Scpharmaceuticals Inc. | 1 | $39 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Bayer | 2 | $35 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $35 |
| Atricure, Inc. | 1 | $32 |
| Teleflex LLC | 2 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| Nevro Corp. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Vivaquant Inc, Dba Rhythm Express | 2 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$2,476
- AVEIR$2,384
- ENSITE$957
- Arctic Front$953
- Micra$930
- Farapulse$598
- Evolution$514
- ENSITE PRECISION$435
- SelectSecure$423
- SAPIEN 3 Ultra RESILIA$367
- LINQ II$365
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$348
- Rapiblyk$339
- Cardiva VASCADE MVP VVCS 6-12F$333
- NA$287
- FFRct$276
- ARCTIC FRONT ADVANCE$259
- Impella$232
- EMBLEM MRI S-ICD$192
- ADVISOR$178
How this compares
$30,285 in reported general payments places this provider in the 40th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $91,845 |
| XareltoRivaroxaban | 23 | $19,744 |
| EntrestoSacubitril/Valsartan | 16 | $11,598 |
| Amiodarone Hcl | 15 | $1,315 |
| Metoprolol Succinate | 77 | $1,298 |
| ClopidogrelClopidogrel Bisulfate | 29 | $366 |
| Atorvastatin Calcium | 49 | $360 |
| Rosuvastatin Calcium | 13 | $310 |
| Metoprolol Tartrate | 48 | $291 |
| Amlodipine Besylate | 48 | $288 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $190 |
| Lisinopril | 27 | $167 |
| Losartan Potassium | 24 | $164 |
| Carvedilol | 23 | $137 |
| Furosemide | 18 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $67 | $91,84568 claims |
| Johnson & JohnsonXarelto | $682 | $19,74423 claims |
| NovartisEntresto | $96 | $11,59816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Chula Vista
- David KrummenSan Diego$7.3M
- Jonathan DukesVentura$2.9M
- Shephal DoshiSanta Monica$2.9M
- Arash AryanaSacramento$2.4M
- Marco PerezStanford$2.1M
- Rahul DoshiLos Angeles$2M
- Mayer RashtianPasadena$1.8M
- Rajesh BankerNewport Beach$1.6M
- Edward GerstenfeldSan Francisco$1.5M
- Jonathan HsuSan Diego$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.